Recent pharmaceutical studies show work in helping patients with high blood pressure and elevated cholesterol levels.
A drug designed to treat patients with rheumatoid arthritis could also make them more susceptible to shingles, according to the results of a recent study.
The Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus Network is a public-private partnership designed to accelerate research into more effective diagnostic and treatment approaches for these autoimmune diseases.
People who smoke and have more sodium in their diets than others could also be more likely to eventually develop rheumatoid arthritis (RA), according to a recent study.
For many patients with chronic conditions such as rheumatoid arthritis, medication adherence is often one of the most challenging aspects of the treatment process, especially when the medications prescribed by their health care professional are prohibitively expensive. A study from Manchester University recently showed that many patients with rheumatoid arthritis are not taking some of their most critical medicines due to rising drug costs.
Researchers at ETH Zurich who were studying mice with rheumatoid arthritis found a product that cured the animals of the condition as a precursor to what could be a much larger and beneficial discovery for humans. A statement from the company said the therapy is an “active substance consisting of two fused components.”